ResearchMoz

Humulin (Type 2 Diabetes) - Analysis and Forecasts to 2020

GlobalData
Published Date » 2012-01-31
No. Of Pages » 44


GlobalDatas pharmaceuticals report, Humulin (Type 2 Diabetes) Analysis and Forecasts to 2020 provides Humulin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Type 2 Diabetes market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Scope

  • Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
  • Analysis and review of Humulin including historical sales data
  • Qualitative and quantitative assessment of market space
  • Analysis of the trends, drivers and restraints shaping and defining the markets
  • In-depth analysis of Humulin including efficacy, safety, pricing, competition and other details which influence its sales potential
  • Detailed sales forecast for 2011-2020 for Humulin in each of the seven major markets
Reasons to buy

  • Understand and capitalize by identifying products that are most likely to ensure a robust return
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drugs performance 
  • Examine the historical sales performance of a drug in seven major markets
  • Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Table of Content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4

2 Introduction 5
2.1 Diabetes 5
2.2 Epidemiology 5
2.2.1 Prevalence 5
2.2.2 Mortality 7
2.3 Etiology and Risk Factors 9
2.3.1 Obesity 9
2.3.2 Sedentary Lifestyle 9
2.3.3 Family History and Genetics 9
2.3.4 Ethnicity 9
2.3.5 Old Age 9
2.4 Economic Impact of Diabetes 9
2.5 GlobalData Report Guidance 11

3 Type 2 Diabetes: Market Characterization 12
3.1 Type 2 Diabetes Market 12
3.2 Type 2 Diabetes Market Forecasts 13
3.3 Type 2 Diabetes Market: Drivers and Restraints 14
3.3.1 Drivers 14
3.3.2 Restraints 15

4 Classification of Diabetes 16
4.1 Types of Diabetes 16
4.1.1 Type 1 Diabetes 16
4.1.2 Type 2 Diabetes 16
4.1.3 Gestational Diabetes 16
4.2 Diabetes Complications 16
4.2.1 Cardiovascular Disease 16
4.2.2 Nephropathy 17
4.2.3 Neuropathy 17
4.2.4 Amputation 17
4.2.5 Retinopathy 17
5 Evolution of Anti-Diabetic Treatments 18

6 Medications 19
6.1 Insulin 19
6.2 Oral Medications 19
6.2.1 Sulfonylureas (SUR) 19
6.2.2 Biguanides (BGDs) 20
6.2.3 Alpha-Glucosidase Inhibitors (AGI) 21
6.2.4 Meglitinides 21
6.2.5 Thiazolidinediones (TZDs) 22
6.2.6 Dipeptidyl Peptidase IV (DPP- 4) Inhibitors 23
6.2.7 Oral Combination Therapy 23
6.3 Other Injectionable Medications 24
6.3.1 Pramlintide 24
6.3.2 Exenatide 24
6.4 Market Share as per Classes in Type 2 Diabetes 24

7 Humulin 25
7.1 Introduction 25
7.2 Mechanism of Action 25
7.3 Different Variants of Humulin 25
7.4 Clinical Studies 25
7.4.1 Safety & Efficacy Study in Humalog & Humulin R 25
7.4.2 Safety & Efficacy Study in Lantus & NPH Insulin 26
7.5 Approval History of Humulin 27
7.6 Factors Affecting Sales 27
7.6.1 First in Class 27
7.6.2 Growing Insulin Market 28
7.6.3 Advantage of Insulin Analogs over Humulin 28
7.6.4 Family of Humulin Products 28
7.6.5 Co-Branding Deal with Wal-Mart 28
7.6.6 Availability as OTC 28
7.6.7 No Competition from Biosimilars 28
7.7 Drug Evaluation 29
7.7.1 Drug Risk Benefit Score 29
7.7.2 Intensity of Competition 30
7.8 Sales Estimates 30
7.8.1 Dosing 30
7.8.2 Market Penetration 30
7.8.3 Annual Cost of Therapy 31
7.8.4 Sales Projections of Humulin 32

8 Diabetes Market: Appendix 41
8.1 Market Definitions 41
8.2 List of Abberiviations 41
8.3 Research Methodology 41
8.3.1 Coverage 42
8.3.2 Secondary Research 42
8.3.3 Forecasting 42
8.3.4 Number of patients approved to take the drug 42
8.3.5 Net Penetration of Drug 43
8.3.6 Net Annual Dosing 43
8.3.7 Annual Cost of Therapy 43
8.4 Drug Sales Estimates Model 43
8.5 Contact Us 43
8.6 Disclaimer 44
8.7 Sources 44

List of Tables


Table 1: Diabetes, World, Prevalence Estimates for the age group 20-79 years (million), 2000-2030 5
Table 2: Diabetes, Top 10 Countries, by Prevalence (million), 2010 and 2030 7
Table 3: Diabetes, Top 10 Countries, Highest Health Expenditures ($bn), 2010 10
Table 4: Type 2 Diabetes, World, Major Marketed Drugs, 2010 12
Table 5: Type 2 Diabetes, World, Major Pipeline Products in Phase III 13
Table 6: Diabetes, Worldwide, Prevalence Estimates, 2010 and 2030 14
Table 7: Overweight*, Global, Prevalence Estimates in Males Aged 15 and above (%), 2005 15
Table 8: Diabetes Drugs Evolution 18
Table 9: Type 2 Diabetes Mellitus Adults 26
Table 10: Efficacy and Insulin Dosage in Type 2 Diabetes Mellitus 27
Table 11: Approval of Humulin in the US 27
Table 12: Drug Risk Benefit Score of Humulin R 29
Table 13: Drug Risk Benefit Score of Humulin N 29
Table 14: Humulin R, Annual Cost of Therapy in Type 2 Diabetes, Global, 2011 31
Table 15: Humulin N, Annual Cost of Therapy in Type 2 Diabetes, Global, 2011 31
Table 16: Humulin PreMix, Annual Cost of Therapy in Type 2 Diabetes, Global, 2011 31
Table 17: Humulin Franchise, Annual Cost of Therapy in Type 2 Diabetes, Global, 2011 31
Table 18: Humulin, Type 2 Diabetes, Global, Sales Estimates ($m), 20022020 32
Table 19: Humulin, Type 2 Diabetes, The US, Sales Estimates ($m), 20022020 33
Table 20: Humulin, Type 2 Diabetes, The UK, Sales Estimates ($m), 20022020 34
Table 21: Humulin, Type 2 Diabetes, France, Sales Estimates ($m), 20022020 35
Table 22: Humulin, Type 2 Diabetes, Germany, Sales Estimates ($m), 20022020 36
Table 23: Humulin, Type 2 Diabetes, Italy, Sales Estimates ($m), 20022020 37
Table 24: Humulin, Type 2 Diabetes, Spain, Sales Estimates ($m), 20022020 38
Table 25: Humulin, Type 2 Diabetes, Japan, Sales Estimates ($m), 20022020 39

List of Figures


Figure 1: Diabetes, World, Comparative Prevalence in Age Group 20-79 years (%), 2010 6
Figure 2: Diabetes, World, Comparative Prevalence in Age Group 20-79 years (%), 2030 6
Figure 3: Diabetes, World, Mortality, 2010 7
Figure 4: Top 10 Causes of Mortality, Worldwide, 2008 8
Figure 5: Type 2 Diabetes, Global, Market Size Forecasts ($bn), 20102020 13
Figure 6: Mechanism of Action of Sulfonylureas 19
Figure 7: Mechanism of Action of Biguanide, Thiazolidinediones, Alpha-Glucosidase Inhibitors 20
Figure 8: Mechanism of Action of Metformin and Alpha-Glucosidase Inhibitors 21
Figure 9: Mechanism of Action of Thiazolidinediones 22
Figure 10: Mechanism of Action of DPP IV Inhibitors 23
Figure 11: Type 2 Diabetes, Global, Branded Market Share By Class (%), 2010 24
Figure 12: Humulin, Type 2 Diabetes, Global, Sales Estimates ($m), 2002-2020 32
Figure 13: Humulin, Type 2 Diabetes, The US, Sales Estimates ($m), 20022020 33
Figure 14: Humulin, Type 2 Diabetes, The UK, Sales Estimates ($m), 20022020 34
Figure 15: Humulin, Type 2 Diabetes, France, Sales Estimates ($m), 20022020 35
Figure 16: Humulin, Type 2 Diabetes, Germany, Sales Estimates ($m), 20022020 36
Figure 17: Humulin, Type 2 Diabetes, Italy, Sales Estimates ($m), 20022020 37
Figure 18: Humulin, Type 2 Diabetes, Spain, Sales Estimates ($m), 20022020 38
Figure 19: Humulin, Type 2 Diabetes, Japan, Sales Estimates ($m), 2002-2020 39
Figure 20: Humulin, Diabetes, Global, Sales Distribution by Country (%), 2020 40
Figure 21: Patients Approved for the Drug 43

Upcoming Reports:

Network Camera And Video Analytics Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecast, 2013 - 2019
By - Transparency Market Research
The global video surveillance market and video analytics market have changed a lot over the years. The need for intelligent security systems, rising criminal activities, and dwelling infrastructure has driven the demand for intelligent security systems. Surveillance systems provide the remote monitoring advantage over the physical security, resulting in wide development of technology across the world. With the developing era of technology and technological advancements, network camera and video analytics market is gaining importance. The network camera market mainly involves...
Photonic Crystals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Photonic crystals are elements that impact the motion of photons. These crystals usually have optical nanostructures. Similar to the periodicity of semiconductor crystals that impact the flow of electrons, photonic crystals impact the flow of photons. They are found naturally and aggressive research has been carried out in order to acquire the varied benefits of the properties it possesses. The market is segmented based on applications that comprise of displays, optical fibers, LEDs, discrete and integrated optical components, image sensors, solar and PV cells, lasers and...
Acrylic Resin Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Acrylic resins are thermoplastic materials derived from certain compounds such as acrylic acid, methacrylic acid and others. Acrylic resins are employed in various application segments including lighting fixtures, automotive, textile, paints & coatings and adhesives among others. Methacrylate represents the largest product segment for acrylic resin. Paints & coatings are the largest application segment for acrylic resin and are expected to grow fastest during the forecast period. End use industries for acrylic resin include construction, consumer goods and automotive among...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

Loss recorded due to heavy investments carried out by Amazon
Jul 25, 2014  
Amazon.com Inc has been investing in newer businesses like consumer electronics and digital content, due to which it has been running into losses for some time now. The loss recorded in the second quarter was by far the highest. In 2014, the stock prices have dropped by 10% with reduced investor confidence in the long term growth investments. The shares of this US based online retailer...
LG Electronics To Invest Huge Capital in R&D Project in South Korea
Jul 25, 2014  
LG Electronics Inc will invest USD 1.26 billion in the construction of a new research and development unit in South Korea’s capital city Seoul. The facility is said to be part of LG’s Science Park project. The 170,000 square meters site will be built in Magok, Seoul and work is expected to begin from August. Once the construction is complete and ready by 2020, the park will house...
Russian Consumer Protection Agency Seeks ban on Some McDonalds Products
Jul 25, 2014  
A lawsuit has been filed in a Moscow court by the Russian consumer protection agency to seek ban on some products from McDonald's Corp's burgers menu, along with its ice creams and shakes menu.  A regional branch of the agency has recently filed a lawsuit asking the court to declare a ban on some products due to some inappropriateness in physical-chemical parameters in the...
High-sodium Diet Increases Risks of Cardiovascular Diseases in Type 2 Diabetics
Jul 24, 2014  
A new research has found relation between the amount of salt in diet of diabetics and their chances of suffering from cardiovascular diseases. The research has stated that diabetics who have a high-salt diet are on a higher risk of having a chronic heart disease as compared to the ones who eat less salt.  The study’s findings provide evidences that support the benefits of a...
Strides Arcolab Bags USFDA Approval for Transplant Drug
Jul 24, 2014  
Indian pharmaceutical company Strides Arcolab has received the approval of the USFDA to sell its transplant drug Tacrolimus in the US market. The capsule is an immune-suppressant that is used for preventing organ rejection that may occur in transplant surgeries of organs such as kidneys, heart or liver in some patients.  USFDA has allowed the sale of the tablets in 5 mg, 1 mg and 0.5...